RARE
Ultragenyx Pharmaceutical Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +6.7% ·
aliran saham -11.6% ·
posisi baru bersih +6.2%
— formula
Fragmentasi kepemilikan — lebih banyak pemegang, agregat kepemilikan lebih kecil
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | -7 | 59.88M | $1.99B | +8 | −14 |
| Q1 2026 | 106 | +4 | 55.54M | $1.16B | +10 | −7 |
| Q4 2025 | 102 | 0 | 62.50M | $1.44B | +1 | — |
| Q3 2025 | 19 | -1 | 45.29M | $1.36B | — | −2 |
| Q2 2025 | 18 | -1 | 33.50M | $1.22B | — | −1 |
| Q1 2025 | 16 | 0 | 17.22M | $623.52M | — | — |
| Q4 2024 | 16 | +1 | 16.41M | $690.18M | +1 | — |
| Q3 2024 | 14 | +2 | 15.84M | $879.45M | +2 | — |
| Q2 2024 | 12 | — | 15.75M | $647.24M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 2.72M | — | $114.54M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.51M | -18.1% | $105.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.51M | -18.1% | $105.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.46M | -41.0% | $103.39M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 1.56M | -0.5% | $65.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 1.56M | -0.5% | $65.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 1.18M | -22.5% | $49.77M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 1.18M | +81.0% | $49.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 1.05M | +27.9% | $44.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.05M | +27.9% | $44.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Norges Bank ✦ (pasif) | 961.79K | +2.2% | $40.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 697.24K | -1.9% | $29.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 614.95K | -18.6% | $25.87M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 286.18K | +496.8% | $12.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 286.18K | +496.8% | $12.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 286.08K | +9.4% | $12.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 280.55K | -73.1% | $11.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 280.55K | -73.1% | $11.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 265.19K | Baru | $11.16M | 0.0% | New | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 254.70K | +39.9% | $10.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Duquesne Family Office ✦ | 85.44K | 0.0% | $3.60M | 0.1% | Held | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Fisher Asset Management | $11.16M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 293 pemegang, 97.86M saham, $1.96B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.